Incannex announces positive results from phase 2 clinical trial investigating the effect of IHL-42X for treatment of obstructive sleep apnoea Jun 3, 2022 | ASX News, Incannex Healthcare (ASX:IHL)
Incannex Appoints FDA Regulatory Affairs Expert Mr Robert B. Clark to the Board of Directors Aug 17, 2022 | ASX News, Incannex Healthcare (ASX:IHL)
Nyrada Quarterly Activities Report & Appendix 4C 30 Jun 2022 Jul 26, 2022 | ASX News, Nyrada Inc (ASX:NYR)